Clinical Trial Update: Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating N-803, an IL-15 super-agonist, to reduce HIV persistence in lymph nodes during acute HIV infection; the study is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• N-803

Snippet

Sponsor: Thai Red Cross AIDS Research Centre | Conditions: HIV/AIDS | Phase 2 | Status: ACTIVE_NOT_RECRUITING